Steven Girgenti

Steven Girgenti has filed trades across 2 companies (mainly through SEC (Form 4)), most often in bioAffinity Technologies, Inc. and Vycor Medical Inc. Between 1 April 2014 and 10 January 2025, the trades on record add up to 63 filings.

No open-market sale appears; the market trades are 1 purchase. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 15 share grants and 1 option exercise.

On 14 January 2025 came the latest disclosure, a share grant in bioAffinity Technologies, Inc. The most recent open-market purchase was published on 8 November 2022, 1,446 days ago. The median gap between a trade and its publication by SEC (Form 4) is 20 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.